US relaxes its guidelines on herbal supplements
BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7229.208/f (Published 22 January 2000) Cite this as: BMJ 2000;320:208- Scott Gottlieb
- New York
The US Food and Drug Administration (FDA) has relaxed guidelines for the sale of herbal supplements. Its decision has opened the way for manufacturers of vitamins, herbs, and dietary supplements to market their products for conditions such as morning sickness, hot flushes, and memory loss in ageing without first proving that they are safe or effective.
The decision marks the latest in a series of legal and regulatory victories for the dietary supplement business, which has been growing since Congress passed a law in 1994 that severely restricted the FDA's authority to regulate it.
Under the new law manufacturers of dietary supplements can make claims about how their products affect the structure or function of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.